Invesco
DTIL icon

Invesco’s Precision BioSciences DTIL Stock Holding History

Invesco’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-836
Closed -$18.9K – 3880
2023
Q1 		$18.9K Buy
836
+266
+47% +$8.77K ﹤0.01% 3818
2022
Q4 		$20.3K Buy
+570
New +$22.5K ﹤0.01% 3970
2022
Q2 		– Sell
-762
Closed -$71K – 4068
2022
Q1 		$71K Buy
762
+4
+0.5% +$543 ﹤0.01% 3898
2021
Q4 		$168K Sell
758
-48
-6% -$13.4K ﹤0.01% 3819
2021
Q3 		$279K Buy
806
+131
+19% +$44.4K ﹤0.01% 3676
2021
Q2 		$254K Buy
675
+286
+74% +$85.9K ﹤0.01% 3699
2021
Q1 		$121K Buy
+389
New +$136K ﹤0.01% 3739
2020
Q1 		– Sell
-2,216
Closed -$923K – 3660
2019
Q4 		$923K Buy
+2,216
New +$696K ﹤0.01% 3036

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Invesco's DTIL Position: Q2 2023 in Review

Invesco sold out of Precision BioSciences (DTIL) in Q2 2023, closing a stake of 836 shares — an estimated $18.9K sold.

Invesco first reported a position in DTIL in Q4 2019 and held it in 8 quarters. The position peaked at $923K in Q4 2019. 77 funds tracked by Wall St. Rank hold DTIL as of Q2 2023.

  • Invesco reported no remaining Precision BioSciences position as of Q2 2023 after selling out during the quarter.
  • Invesco sold 836 Precision BioSciences shares in Q2 2023, an estimated $18.9K.
  • Invesco first reported a position in Precision BioSciences in Q4 2019 and held it in 8 quarters.
  • Invesco's Precision BioSciences position peaked at $923K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.